Search Within

Megan Dacek

Formats
  1. Journal Article (10)
  2. Meeting Abstract (5)
  3. Editorial (1)
  4. Review (1)
Groups
  1. GSK Faculty (17)
  2. MSK Grad Students (17)
  3. Sloan Kettering Institute Postdocs (17)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)
  5. Center for Hematologic Malignancies (16)
  6. Molecular Pharmacology and Chemistry Program Faculty (16)

More Groups

People
  1. David Scheinberg (15)
  2. Christopher Bourne (11)
  3. Keifer Kurtz (8)
  4. Thomas Gardner (8)
  5. Leila Peraro (5)
  6. Lukas Carter (5)

More People

Years
  1. 2023 (3)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (1)
Publications
  1. Blood (3)
  2. Cancer Immunology Research (2)
  3. Molecular Therapy (2)
  4. Bioconjugate Chemistry (1)
  5. Cancers (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (3)
  3. American Society of Hematology (3)
  4. Elsevier Inc. (2)
  5. American Chemical Society (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A TCR mimic antibody-directed CAR T cell specific for intracellular NDC80 is broadly cancer reactive and displays high activity against hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Yang, Z.; Liu, J.; Korontsvit, T.; Mun, S. S.; Peraro, L.; Gardner, T. J.; Bourne, C.; Dacek, M. M.; Dao, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CAR chase: Where do engineered cells go in humans?
    Editorial

    Krebs, S.; Dacek, M. M.; Carter, L. M.; Scheinberg, D. A.; Larson, S. M.
    Frontiers in Oncology (2020)

    Fulltext@MSK | Save
  • Targeted cellular micropharmacies: Cells engineered for localized drug delivery
    Review

    Gardner, T. J.; Bourne, C. M.; Dacek, M. M.; Kurtz, K.; Malviya, M.; Peraro, L.; Silberman, P. C.; Vogt, K. C.; Unti, M. J.; Brentjens, R.; more...
    Cancers (2020)

    Fulltext@MSK | Save
  • Targetable micropharmacies: Cells that produce small-molecule drugs in situ at the tumor site
    Meeting Abstract

    Gardner, T. J.; Lee, P.; Wijewarnasuriya, D.; Kinarivala, N.; Bourne, C.; Kurtz, K.; Corless, B.; Dacek, M.; Mo, G.; Brentjens, R.; more...
    Molecular Therapy (2020)

    Fulltext@MSK | Save
  • ALK and RET inhibitors promote HLA class I antigen presentation and unmask new antigens within the tumor immunopeptidome
    Journal Article

    Oh, C. Y.; Klatt, M. G.; Bourne, C.; Dao, T.; Dacek, M. M.; Brea, E. J.; Mun, S. S.; Chang, A. Y.; Korontsvit, T.; Scheinberg, D. A.
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • A PET imaging strategy for interrogating target engagement and oncogene status in pancreatic cancer
    Journal Article

    Henry, K. E.; Dacek, M. M.; Dilling, T. R.; Caen, J. D.; Fox, I. L.; Evans, M. J.; Lewis, J. S.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Quantitative self-assembly prediction yields targeted nanomedicines
    Journal Article

    Shamay, Y.; Shah, J.; Işık, M.; Mizrachi, A.; Leibold, J.; Tschaharganeh, D. F.; Roxbury, D.; Budhathoki-Uprety, J.; Nawaly, K.; Sugarman, J. L.; more...
    Nature Materials (2018)

    Fulltext@MSK | Save